January 5, 2018 / 12:14 PM / a year ago

BRIEF-Kala Pharmaceuticals Announces NDA For Inveltystm Accepted By U.S. FDA

Jan 5 (Reuters) - Kala Pharmaceuticals Inc:

* KALA PHARMACEUTICALS ANNOUNCES NEW DRUG APPLICATION FOR INVELTYSTM (KPI-121 1%) HAS BEEN ACCEPTED FOR REVIEW BY THE U.S. FOOD AND DRUG ADMINISTRATION

* KALA PHARMACEUTICALS INC - BRAND NAME FOR KPI-121 1%, INVELTYS, HAS BEEN CONDITIONALLY APPROVED BY FDA

* KALA PHARMA-FDA INDICATES APPLICATION FOR INVELTYSTM SUFFICIENTLY COMPLETE TO PERMIT SUBSTANTIVE REVIEW,SET PDUFA TARGET ACTION DATE OF AUGUST 24,2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below